The novel HLA-A*02:787 allele was identified by polymerase chain reaction sequence-based typing.


Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
08 2020
Historique:
received: 17 02 2020
revised: 19 02 2020
accepted: 20 02 2020
pubmed: 28 2 2020
medline: 22 6 2021
entrez: 28 2 2020
Statut: ppublish

Résumé

HLA-A*02:787 differs from HLA-A*02:07:01 by a single nucleotide substitution at position 278 C > T.

Identifiants

pubmed: 32103636
doi: 10.1111/tan.13850
doi:

Substances chimiques

HLA-A Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

211-213

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Carey BS, Poulton KV, Poles A. Factors affecting HLA expression: a review. Int J Immunogenet. 2019;46:307-320.
Robinson J, Barker DJ, Georgiou X, Cooper MA, Flicek P. Marsh SGE.IPD-IMGT/HLA database. Nucleic Acids Res. 2020;48:D948-D955.
Chen NY, He JJ, He J, Zhu FM, Lv HJ. Two novel alleles, HLA-A*02:07:06 and HLA-A*02:426, were identified in Chinese individuals. Tissue Antigens. 2015;85:499-501.
Zhang W, He Y, Wang W, et al. HLA-A locus allelic dropout in sanger sequence-based typing due to the single nucleotide polymorphism of exon 1. Int J Immunogenet. 2015;42:457-460.
Marsh SGE, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75:291-455.

Auteurs

Wei Zhang (W)

HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, People's Republic of China.
Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, People's Republic of China.

Rui Fu (R)

HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, People's Republic of China.
Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, People's Republic of China.

Fang Wang (F)

HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, People's Republic of China.
Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, People's Republic of China.

Ji He (J)

HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, People's Republic of China.
Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, People's Republic of China.

Faming Zhu (F)

HLA typing laboratory, Blood Center of Zhejiang Province, Hangzhou, People's Republic of China.
Key Laboratory of Blood Safety Research, Zhejiang Province, Hangzhou, People's Republic of China.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH